Professional Documents
Culture Documents
Omega 3 Ethyl Esters Farmacopeia
Omega 3 Ethyl Esters Farmacopeia
Table 1
of eicosapentaenoic acid ethyl ester and docosahexae-
noic acid ethyl ester• (IRA 1-Jan-2016) in Standard solution •1b .
Acceptance
and Standard solution 1a,• (IRA 1-Jan-2016) as obtained in the Criteria II
Assay. (For articles
labeled as
Omega-3-
Add the following: Acid Ethyl
Acceptance Esters type
•• B. It meets the acceptance criteria in Table 1 of the
.
Criteria I A)
Assay.• (IRA 1-Jan-2016) Relative
Retention
ASSAY
Name Time NLT NMT NLT NMT
C18:3 n−3, EEa . 0.585 — — — —
Change to read: C18:4 n−3, EEb . 0.608 — — — —
C20:4 n−3, EEc 0.777 — — — —
• CONTENT OF EPAEE, DHAEE, AND TOTAL OMEGA-3-ACID
.
EPAee + DHAee g g g g
Test solution 3, and Test solution 4• (IRA 1-Jan-2016) Total omega-3- 90% 78%
Calculate the content of EPAee and DHAee in the por- acid ethyl — (w/ — (w/ —
tion of Omega-3-Acid Ethyl Esters taken: esters w) w)
a Alpha-linolenic acid ethyl ester.
Result = (RU/RS) × (CS/CU) .
(mg/mL)
Hold Time
• CHOLESTEROL Initial Tempera- Final at Final
Internal standard stock solution: 3 mg/mL of 5α- Tempera- ture Tempera- Tempera-
cholestane in n-heptane. [NOTE—Prepare fresh before ture Ramp ture ture
use.] (°) (°/min) (°) (min)
Internal standard solution: 0.3 mg/mL of 5α-choles- 170 0 170 1
tane in n-heptane. [NOTE—Prepare fresh before use.] 170 4 320 1.5
Standard stock solution: 3.0 mg/mL of cholesterol in
n-heptane. [NOTE—This solution is stable for 6 months Carrier gas: Helium
stored in a freezer.] Transfer 1.0 mL of this solution to Flow rate: 1.3 mL/min
a 10.0-mL volumetric flask. Dilute with n-heptane to Injection volume: 1 µL
volume. [NOTE—Prepare this solution fresh daily.] Injection type: Splitless injection system
Standard solution: Transfer 1.0 mL each of the Stan- System suitability
dard stock solution and the Internal standard solution to Sample: System suitability solution
a 15-mL centrifuge tube. Prepare as directed in the Suitability requirements
Sample solution beginning with “Evaporate to dryness”. Resolution: NLT 1.2 between alpha tocopherol and
Alpha tocopherol stock solution: 1.5–2.0 mg/mL of cholesterol
USP Alpha Tocopherol RS in n-heptane. [NOTE—This so- Analysis
lution is stable for 12 months stored in a freezer.] Samples: Standard solution and Sample solution
System suitability solution: Mix 1.0 mL of the Stan- Calculate the content of total cholesterol in the portion
dard stock solution, 1.0 mL of the Internal standard of Omega-3-Acid Ethyl Esters taken:
stock solution, and 2.0 mL of the Alpha tocopherol stock
solution in a 50-mL volumetric flask. Evaporate to dry- Result = (RU/RS) × (WS/WU)
ness with the aid of heat, and dilute with ethyl acetate
to volume. Dilute 1.0 mL of this solution with ethyl RU = peak area ratio of the cholesterol peak to the
acetate to 10.0 mL. [NOTE—This solution is stable for 6 internal standard from the Sample solution
months stored in a freezer.] RS = peak area ratio of the cholesterol peak to the
Sample solution: Transfer 100 mg of Omega-3-Acid internal standard from the Standard solution
Ethyl Esters to a 15-mL centrifuge tube. Add 1.0 mL of WS = weight of cholesterol in the Standard solution
the Internal standard solution. Evaporate to dryness at (mg)
about 50° with a gentle stream of nitrogen. Add WU = weight of Omega-3-Acid Ethyl Esters in the
0.5 mL of 50% potassium hydroxide and 3 mL of alco- Sample solution (g)
hol, fill the tube with nitrogen, and cap. Heat the sam- Acceptance criteria: NMT 3.0 mg/g
ple at 100° for 60 min, using a heating block. Cool for • OLIGOMERS
about 10 min. Add 6 mL of water to the tube, and Mobile phase: Tetrahydrofuran
shake for 1 min. Extract the solution four times with System suitability solution: Monodocosahexaenoin,
2.5-mL portions of ethyl ether, using a vortex mixer or didocosahexaenoin, and tridocosahexaenoin in Mobile
suitable shaker for 1 min for each extraction. Transfer phase, with concentrations of about 0.5, 0.3, and
and combine the extracts into a large centrifuge tube, 0.2 mg/mL, respectively. [NOTE—Suitable grades of
and wash with 5 mL of water, mixing completely with monodocosahexaenoin, didocosahexaenoin, and
gentle inversion. Remove the water phase, and add tridocosahexaenoin may be obtained from Nu-Chek
5 mL of 0.5 M potassium hydroxide to the ether Prep.]
phase, mixing carefully to avoid an emulsion. Remove Sample solution 1: 5.0 mg/mL of Omega-3-Acid Ethyl
the potassium hydroxide, and add another 5 mL of Esters in tetrahydrofuran
water, mixing carefully. Transfer the ether phase to a Sample solution 2: [NOTE—Use Sample solution 2
small centrifuge tube. [NOTE—If an emulsion has oc- where the results of this test using Sample solution 1
curred, a small amount of sodium chloride may be exceed the Acceptance criteria due to the presence of
added to obtain a separation of the phases.] Evaporate monoglycerides.] Weigh 50 mg of Omega-3-Acid Ethyl
the ether phase to dryness under a stream of nitrogen Esters into a quartz tube, add 1.5 mL of a 20-g/L solu-
with careful heating. Dissolve the sample in 600 µL of tion of sodium hydroxide in methanol, cover with ni-
ethyl acetate, and mix well. Transfer 200 µL of this so- trogen, cap tightly with a polytef-lined cap, mix, and
lution to a sample vial, and dilute with ethyl acetate to heat on a water bath for 7 min. Allow to cool. Add
about 2 mL. 2.0 mL of boron trichloride–methanol solution, cover
Chromatographic system with nitrogen, cap tightly, mix, and heat on a water
(See Chromatography 〈621〉, System Suitability.) bath for 30 min. Cool to 40°–50°, add 1 mL of isooc-
Mode: GC tane, cap, and shake vigorously for NLT 30 s. Immedi-
Detector: Flame ionization ately add 5 mL of saturated sodium chloride solution,
Column: 0.25-mm × 30-m capillary; coated with a cover with nitrogen, cap, and shake thoroughly for
G27 phase of 0.25-µm thickness NLT 15 s. Transfer the upper layer to a separate tube.
Temperatures Shake the methanol layer with 1 mL of isooctane. Wash
Injection port: 320° the combined isooctane extracts with two quantities,
Detector: 300° each of 1 mL of water. Carefully evaporate the solvent
Column: See •Table 2.
.
Acceptance criteria: NMT 0.55, determined at 233 Assay and the Limit of Non-Omega-3-Acid Ethyl Esters are
nm, with isooctane being used as the blank labeled as Omega-3-Acid Ethyl Esters type A.• (IRA 1-Jan-2016)
• USP REFERENCE STANDARDS 〈11〉
ADDITIONAL REQUIREMENTS USP Docosahexaenoic Acid Ethyl Ester RS
• PACKAGING AND STORAGE: Preserve in tight, light-resistant All cis-4,7,10,13,16,19-docosahexaenoic ethyl ester.
containers under a nitrogen atmosphere. Store at con- C24H36O2 356.55
trolled room temperature. USP Eicosapentaenoic Acid Ethyl Ester RS
All cis-5,8,11,14,17-eicosapentaenoic ethyl ester.
Change to read: C22H34O2 330.51
USP Methyl Tricosanoate RS
• LABELING: The label states the content of DHA ethyl es- Tricosanoic acid methyl ester.
ter and EPA ethyl ester in mg/g, the sum of the EPA and C24H48O2 368.64
DHA ethyl esters contents in mg/g, and the content of USP Alpha Tocopherol RS
the total omega-3-acid ethyl esters in weight percentage
(w/w). It also states the name of any added antioxidant.
•Articles intended to meet Acceptance Criteria II of the
.